Video
CDMO Perspective on Partnering with Clients from Phase I through Commercialization
Summary: During this webinar, experts present the principles, mechanisms and several downstream applications of patented twin-screw granulation technique for oral solid dosage forms.
View Now
Webinars
Twin-Screw Granulation as a Viable Pharmaceutical Process in the Shifting Manufacturing Paradigm
Summary: During this webinar, experts present the principles, mechanisms and several downstream applications of patented twin-screw granulation technique for oral solid dosage forms.
View Now
Webinars
Tackling Bioavailability Challenges for the Next Generation of Small Molecules
Summary: In this webinar, speakers will share industry insights into small molecule drug development advancements and discuss innovative, scalable drug delivery technologies proven to address the industry’s growing need for improving solubility and enhancing bioavailability.
View Now
Webinars
Small Molecule Orphan Drugs: Status Quo, Challenges, and Perspectives
Summary: In this webinar, experts discuss the key drivers and challenges of orphan drug development and manufacturing.
View Now
Executive Summary
Better Decisions for Phase 1 Clinical Trials Using Integrated Design Models
Summary: Learn how innovative trial designs, on-demand manufacturing, real-time clinical data-based dose adjustments, and partnering with experienced formulators and Contract Research Organizations (CROs) can enable faster, better decision making during phase 1 clinical trials.
View Now
Article
Current State & Challenges of Phase 1 Oral Small Molecule Drug Development & Outsourcing
Summary: A recent survey explored the attitudes and changing perceptions of experienced Phase 1 development professionals toward development challenges and available solutions.
View Now
Webinars
Webinar: ADC’s Are Back Stronger Than Ever: How, Why & What’s Next
Summary: Mike Riley, President, Catalent Biologics, will discuss the latest trends in ADC discovery and development, with a focus on how next generation pipelines are being shaped by payload and linker chemistry innovations, including those from Catalent’s award-winning SMARTag® ADC platform.
View Now
Webinars
The Biopharma Industry in 2023
Summary: In this webinar Endpoints Editor, John Carroll sits down with Catalent CEO, Alessandro Maselli to talk about the year ahead, offering their projections for what 2023 holds in store for the biopharma industry
View Now
Executive Summary
Unraveling the Complexities in Nasal Vaccine Development, Manufacturing, and Device Selection
Summary: In this article experts shared their insights on developing intranasal products and scaling them for commercial supply.
View Now
Webinars
A Stagewise Approach to High Potency Drug Product Clinical Development & Commercialization
In this webinar, experts discuss how companies with promising HPAPIs can overcome development challenges in order to bring innovative medicines to market.
View Now
